Загрузка...
Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular endothelial growth factor (anti-VEGF) having become th...
Сохранить в:
| Опубликовано в: : | Cells |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307715/ https://ncbi.nlm.nih.gov/pubmed/34359853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10071683 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|